Sfoglia per Autore
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab
2012 Petrioli R; Licchetta A; Roviello G; Pascucci A; Francini E; Bargagli G; Conca R; Miano ST; Marzocca G; Francini G; Multidisciplinary Oncology Group On Gastrointestinal Tumors
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report
2013 Roviello Giandomenico; Petrioli Roberto; Cerase Alfonso; Marsili Stefania; Miracco Clelia; Rubino Giovanni; Tini Paolo
Time for a revision on the role of PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatment for patients with metastatic hormone-refractory prostate cancer
2013 Roviello G; Petrioli R; Francini E
PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials
2014 Francini E; Petrioli R; Rossi G; Laera L; Roviello G
Effects of abiraterone acetate on chronic kidney disease in 2 patients with metastatic castration-resistant prostate cancer
2014 Francini E; Petrioli R; Fiaschi AI; Laera L; Roviello G
Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer
2014 Francini E; Fiaschi AI; Petrioli R; Francini F; Bianco V; Perrella A; Paganini G; Laera L; Roviello G
No clear evidence of a clinical benefit of a sequential therapy regimen with abiraterone acetate and enzalutamide
2014 Francini E; Petrioli R; Roviello G
How to optimize the sequential use of novel therapeutics in metastatic prostate cancer patients? Response should be found in prostate cancer tissue
2014 Francini E; Roviello G
Safety of sorafenib therapy in elderly adults with advanced hepatocellular carcinoma
2014 Francini E; Mazzaroppi S; Fiaschi AI; Petrioli R; Laera L; Roviello G; Pira T; Pellicelli AM; Bianco V
Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience
2015 Petrioli, Roberto; Roviello, Giandomenico; Laera, Letizia; Luzzi, Luca; Paladini, Piero; Ghiribelli, Claudia; Voltolini, Luca; Martellucci, Ignazio; Bianco, Vincenzo; Francini, Edoardo
The third line of treatment for metastatic prostate cancer patients: Option or strategy?
2015 Roviello G; Petrioli R; Laera L; Francini E
Targeted Therapies for Prostate Cancer
2015 Petrioli R; Francini E; Fiaschi AI; Laera L; Roviello G
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience
2015 PETRIOLI, ROBERTO; Francini, Edoardo; ROVIELLO, FRANCO; MARRELLI, DANIELE; FIASCHI, ANNA IDA; LAERA, LETIZIA; ROSSI, GIULIA; Bianco, V; Brozzetti, S; ROVIELLO, GIANDOMENICO
Reduced Dose of Abiraterone Acetate with Concomitant Low-dose Prednisone in the Treatment of ≥ 85 Year-old Patients with Advanced Castrate-resistant Prostate Cancer
2015 Petrioli R; Francini E; Fiaschi AI; Laera L; Miano ST; De Rubertis G; Roviello G
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results
2015 ROVIELLO, FRANCO; ROVIELLO, GIANDOMENICO; PETRIOLI, ROBERTO; MARRELLI, DANIELE
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer
2015 Petrioli R; Roviello G; Fiaschi Ai; Laera L; Bianco V; Ponchietti R; Barbanti G; Francini E.
Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience
2015 Petrioli R; Roviello G; Fiaschi AI; Laera L; Miano ST; De Rubertis G; Barbanti G; Bianco V; Brozzetti S; Francini E.
The distinctive nature of adenocarcinoma of the lung
2015 Roviello G
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status
2015 PETRIOLI, ROBERTO; Francini, Edoardo; ROVIELLO, FRANCO; MARRELLI, DANIELE; MIANO, SALVATORA TINDARA; FIASCHI, ANNA IDA; LAERA, LETIZIA; BELLINI, MARCO ANTONIO; ROVIELLO, GIANDOMENICO
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
2015 PETRIOLI, ROBERTO; ROVIELLO, GIANDOMENICO; FIASCHI, ANNA IDA; LAERA, LETIZIA; MARRELLI, DANIELE; ROVIELLO, FRANCO; Francini, Edoardo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile